Skip to main content
Top

Clinical & Experimental Metastasis

Issue 6/2004

Content (10 Articles)

SGK1, a potential regulator of c-fms related breast cancer aggressiveness

Jacob Tangir, Nathalie Bonafé, Maureen Gilmore-Hebert, Octavian Henegariu, Setsuko K. Chambers

Arg and DAP3 expression was correlated with human thymoma stage

Hidefumi Sasaki, Nobuyuki Ide, Haruhiro Yukiue, Yoshihiro Kobayashi, Ichiro Fukai, Yosuke Yamakawa, Yoshitaka Fujii

Breast cancer cells with inhibition of p38α have decreased MMP-9 activity and exhibit decreased bone metastasis in mice

Catalina Suarez-Cuervo, Melinda A. Merrell, Latania Watson, Kevin W. Harris, Eben L. Rosenthal, H. Kalervo. Väänänen, Katri S. Selander

LCC15-MB Cells are MDA-MB-435: A Review of Misidentified Breast and prostate cell lines

Erik W. Thompson, Mark Waltham, Susan J. Ramus, Anne-Marie Hutchins, Jane E. Armes, Ian G. Campbell, Elizabeth D. Williams, Phillip R. Thompson, James M. Rae, Michael D. Johnson, Robert Clarke

Common origins of MDA-MB-435 cells from various sources with those shown to have melonoma properties

James M. Rae, Susan J. Ramus, Mark Waltham, Jane E. Armes, Ian G. Campbell, Robert Clarke, Robert J. Barndt, Michael D. Johnson, Erik W. Thompson

A Fluorescent Orthotopic Mouse Model for Reliable Measurement and Genetic Modulation of Human Neuroblastoma Metastasis

K. Cecilia Henriksson, Malin A. E. Almgren, Ralph Thurlow, Nissi M. Varki1, Christina L. ␣Chang

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine